(0)サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1461236

癌情報システム市場の評価：製品&サービス別、用途別、エンドユーザー別、地域別の機会および予測 (2017-2031年)

Oncology Information System Market Assessment, By Product and Service, By Application, By End-user, By Region, Opportunities and Forecast, 2017-2031F

出版日
ページ情報
英文 220 Pages
納期
3～5営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.91円
癌情報システム市場の評価：製品&サービス別、用途別、エンドユーザー別、地域別の機会および予測 (2017-2031年)
出版日: 2024年04月09日
発行: Market Xcel - Markets and Data
ページ情報: 英文 220 Pages
納期: 3～5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の癌情報システムの市場規模は、2023年の32億3,000万米ドルから、2024年から2031年の予測期間中は7.35%のCAGRで推移し、2031年には57億米ドルの規模に成長すると予測されています。

癌情報システム (OIS) 市場の成長は、主に世界の癌患者の増加によって後押しされています。患者情報とデータ管理を合理化するためのOISに対する需要が高まり、さまざまなタイプのOISソフトウェアが急増しています。さらに、企業による癌研究への投資の増加が市場拡大を促進すると予想されています。2030年までに子宮頸癌を公衆衛生上の懸念から排除するというWorld Health Organization (WHO) の目標に沿って、各国政府は癌のR&Dへの資金拠出を増やしています。このようなイニシアチブは、認知度を高めるだけでなく、市場成長の原動力にもなっています。

癌患者の増加：

癌は依然として世界的に重大な死亡原因であることから、技術とソフトウェアシステムの統合が癌治療において重要な役割を果たしています。特にライフスタイルの変化による高齢者の癌罹患率の増加が、癌治療情報システム需要の主要な促進要因となっています。2022年の予測では、新たに2,000万人が癌に罹患し、970万人が死亡し、診断から5年以内の生存者は約5,350万人です。統計によると、5人に1人が一生のうちに癌の診断に直面し、男性の9人に1人、女性の12人に1人がこの病気に罹患します。電子カルテ (EHR) システムは、ヘルスケア専門家の間でエビデンスに基づいた意思決定をサポートし、患者のケア連携を合理化するために採用されています。癌情報システムはEHRを管理し、患者中心のサービスを向上させ、病気の病因を理解し、病気の早期発見を可能にし、より効果的な治療法へのアクセスを容易にします。正確で効率的な放射線検出システムの需要は、患者が治療中に正確な放射線量を確実に受けるために不可欠です。癌治療の進歩は、精密医療とオーダーメイドの治療計画に向かっており、先端技術による診断結果を効果的に活用するための情報システムの活用が重要であることを強調しています。これらのシステムは文書を保存、処理、共有し、診断の徹底的な分析と適切な治療戦略の策定を可能にします。2022年1月に発表されたAmerican Cancer Society Journalの記事によると、米国で報告された癌患者数は約190万人に増加しています。

ヘルスケアITの急成長

ヘルスケアIT市場は、医療技術、ヘルスケア、医療機器、デジタルヘルスなどさまざまな分野と交わり、近代的な技術の進歩によって従来の医療提供システムや研究システムを再構築しています。統合されたヘルスケアITエコシステムは、プロセスを合理化し、非効率性を削減しながら、癌治療の継続性におけるギャップに対処します。ヘルスケアの冗長性を最小限に抑え、病院システムが医療提供者の垣根を越えて患者中心のケアをシームレスに提供できるようにします。EMR、RIS、PACS、VNA、治療計画ソリューションなど、さまざまなヘルスケアITソリューションを採用することで、医療機関はケアの質を高めながら運営経費を削減することができ、主要なエンドユーザー層の市場需要を牽引しています。

クラウドベースのソリューションは、従来のオンプレミス型ソリューションに比べて、アクセス性、拡張性、費用対効果の向上など、数多くの利点を備えています。クラウドベースのソリューションは、EHRシステムやその他のヘルスケアITプラットフォームとのシームレスな統合を容易にし、さまざまなヘルスケア環境での患者データの共有とコラボレーションを促進します。AIとMLアルゴリズムは、複雑な医療画像データの分析と解釈を合理化し、癌診断と治療計画の精度と効率を高めます。

当レポートでは、世界の癌情報システムの市場を調査し、市場の定義と概要、市場規模の推移・予測、各種区分・地域別の詳細分析、産業構造、市場成長への影響因子の分析、ケーススタディ、競合情勢、主要企業のプロファイルなどをまとめています。

目次

第1章 調査手法

第2章 プロジェクトの範囲と定義

第3章 エグゼクティブサマリー

第4章 癌情報システム市場の展望

  • 市場規模・予測
  • 製品・サービス別
    • 患者情報システム
    • 治療計画システム
    • 治療管理・医療画像解析システム
    • コンサルティング・最適化サービス
    • 実装サービス
    • アフターサービス・メンテナンスサービス
  • 用途別
    • 腫瘍内科
    • 放射線腫瘍
    • 外科腫瘍
  • エンドユーザー別
    • 病院
    • 癌ケアセンター
    • 政府機関
    • 研究施設
    • その他
  • 地域別
    • 北米
    • 欧州
    • アジア太平洋
    • 南米
    • 中東・アフリカ
  • 企業別市場シェア

第5章 癌情報システム市場の展望：地域別

  • 北米
  • 欧州
  • アジア太平洋
  • 南米
  • 中東・アフリカ

第6章 市場マッピング

  • 製品&サービス別
  • 用途別
  • エンドユーザー別
  • 地域別

第7章 マクロ環境と産業構造

  • 需給分析
  • 輸出入分析
  • PESTEL分析
  • ポーターのファイブフォース分析

第8章 市場力学

  • 成長促進要因
  • 成長抑制要因 (課題・障壁)

第9章 規制の枠組みとイノベーション

  • 特許情勢
  • イノベーション/新興技術

第10章 主要企業の情勢

  • 市場リーダー上位5社の競合マトリックス
  • 市場リーダー上位5社の市場収益分析
  • M&A・ジョイントベンチャー (該当する場合)
  • SWOT分析 (参入5社)

第11章 ケーススタディ

第12章 主要企業の展望

  • Siemens Healthineers
  • F. Hoffmann-La Roche AG
  • McKesson Corporation
  • Koninklijke Philips N.V.
  • GE HealthCare Technologies, Inc.
  • Elekta Medical Systems India Pvt. Ltd.
  • IBM Watson Health
  • Oracle Cerner
  • Epic Systems Corporation
  • RaySearch Laboratories AB

第13章 戦略的提言

第14章 お問い合わせ・免責事項

図表

List of Tables

  • Table 1. Pricing Analysis of Products from Key Players
  • Table 2. Competition Matrix of Top 5 Market Leaders
  • Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1.Global Oncology Information System Market, By Value, In USD Billion, 2017-2031F
  • Figure 2.Global Oncology Information System Market Share (%), By Product and Service, 2017-2031F
  • Figure 3.Global Oncology Information System Market Share (%), By Application, 2017-2031F
  • Figure 4.Global Oncology Information System Market Share (%), By End-user, 2017-2031F
  • Figure 5.Global Oncology Information System Market Share (%), By Region, 2017-2031F
  • Figure 6.North America Oncology Information System Market, By Value, In USD Billion, 2017-2031F
  • Figure 7.North America Oncology Information System Market Share (%), By Product and Service, 2017-2031F
  • Figure 8.North America Oncology Information System Market Share (%), By Application, 2017-2031F
  • Figure 9.North America Oncology Information System Market Share (%), By End-user, 2017-2031F
  • Figure 10.North America Oncology Information System Market Share (%), By Country, 2017-2031F
  • Figure 11.United States Oncology Information System Market, By Value, In USD Billion, 2017-2031F
  • Figure 12.United States Oncology Information System Market Share (%), By Product and Service, 2017-2031F
  • Figure 13.United States Oncology Information System Market Share (%), By Application, 2017-2031F
  • Figure 14.United States Oncology Information System Market Share (%), By End-user, 2017-2031F
  • Figure 15.Canada Oncology Information System Market, By Value, In USD Billion, 2017-2031F
  • Figure 16.Canada Oncology Information System Market Share (%), By Product and Service, 2017-2031F
  • Figure 17.Canada Oncology Information System Market Share (%), By Application, 2017-2031F
  • Figure 18.Canada Oncology Information System Market Share (%), By End-user, 2017-2031F
  • Figure 19.Mexico Oncology Information System Market, By Value, In USD Billion, 2017-2031F
  • Figure 20.Mexico Oncology Information System Market Share (%), By Product and Service, 2017-2031F
  • Figure 21.Mexico Oncology Information System Market Share (%), By Application, 2017-2031F
  • Figure 22.Mexico Oncology Information System Market Share (%), By End-user, 2017-2031F
  • Figure 23.Europe Oncology Information System Market, By Value, In USD Billion, 2017-2031F
  • Figure 24.Europe Oncology Information System Market Share (%), By Product and Service, 2017-2031F
  • Figure 25.Europe Oncology Information System Market Share (%), By Application, 2017-2031F
  • Figure 26.Europe Oncology Information System Market Share (%), By End-user, 2017-2031F
  • Figure 27.Europe Oncology Information System Market Share (%), By Country, 2017-2031F
  • Figure 28.Germany Oncology Information System Market, By Value, In USD Billion, 2017-2031F
  • Figure 29.Germany Oncology Information System Market Share (%), By Product and Service, 2017-2031F
  • Figure 30.Germany Oncology Information System Market Share (%), By Application, 2017-2031F
  • Figure 31.Germany Oncology Information System Market Share (%), By End-user, 2017-2031F
  • Figure 32.France Oncology Information System Market, By Value, In USD Billion, 2017-2031F
  • Figure 33.France Oncology Information System Market Share (%), By Product and Service, 2017-2031F
  • Figure 34.France Oncology Information System Market Share (%), By Application, 2017-2031F
  • Figure 35.France Oncology Information System Market Share (%), By End-user, 2017-2031F
  • Figure 36.Italy Oncology Information System Market, By Value, In USD Billion, 2017-2031F
  • Figure 37.Italy Oncology Information System Market Share (%), By Product and Service, 2017-2031F
  • Figure 38.Italy Oncology Information System Market Share (%), By Application, 2017-2031F
  • Figure 39.Italy Oncology Information System Market Share (%), By End-user, 2017-2031F
  • Figure 40.United Kingdom Oncology Information System Market, By Value, In USD Billion, 2017-2031F
  • Figure 41.United Kingdom Oncology Information System Market Share (%), By Product and Service, 2017-2031F
  • Figure 42.United Kingdom Oncology Information System Market Share (%), By Application, 2017-2031F
  • Figure 43.United Kingdom Oncology Information System Market Share (%), By End-user, 2017-2031F
  • Figure 44.Russia Oncology Information System Market, By Value, In USD Billion, 2017-2031F
  • Figure 45.Russia Oncology Information System Market Share (%), By Product and Service, 2017-2031F
  • Figure 46.Russia Oncology Information System Market Share (%), By Application, 2017-2031F
  • Figure 47.Russia Oncology Information System Market Share (%), By End-user, 2017-2031F
  • Figure 48.Netherlands Oncology Information System Market, By Value, In USD Billion, 2017-2031F
  • Figure 49.Netherlands Oncology Information System Market Share (%), By Product and Service, 2017-2031F
  • Figure 50.Netherlands Oncology Information System Market Share (%), By Application, 2017-2031F
  • Figure 51.Netherlands Oncology Information System Market Share (%), By End-user, 2017-2031F
  • Figure 52.Spain Oncology Information System Market, By Value, In USD Billion, 2017-2031F
  • Figure 53.Spain Oncology Information System Market Share (%), By Product and Service, 2017-2031F
  • Figure 54.Spain Oncology Information System Market Share (%), By Application, 2017-2031F
  • Figure 55.Spain Oncology Information System Market Share (%), By End-user, 2017-2031F
  • Figure 56.Turkey Oncology Information System Market, By Value, In USD Billion, 2017-2031F
  • Figure 57.Turkey Oncology Information System Market Share (%), By Product and Service, 2017-2031F
  • Figure 58.Turkey Oncology Information System Market Share (%), By Application, 2017-2031F
  • Figure 59.Turkey Oncology Information System Market Share (%), By End-user, 2017-2031F
  • Figure 60.Poland Oncology Information System Market, By Value, In USD Billion, 2017-2031F
  • Figure 61.Poland Oncology Information System Market Share (%), By Product and Service, 2017-2031F
  • Figure 62.Poland Oncology Information System Market Share (%), By Application, 2017-2031F
  • Figure 63.Poland Oncology Information System Market Share (%), By End-user, 2017-2031F
  • Figure 64.South America Oncology Information System Market, By Value, In USD Billion, 2017-2031F
  • Figure 65.South America Oncology Information System Market Share (%), By Product and Service, 2017-2031F
  • Figure 66.South America Oncology Information System Market Share (%), By Application, 2017-2031F
  • Figure 67.South America Oncology Information System Market Share (%), By End-user, 2017-2031F
  • Figure 68.South America Oncology Information System Market Share (%), By Country, 2017-2031F
  • Figure 69.Brazil Oncology Information System Market, By Value, In USD Billion, 2017-2031F
  • Figure 70.Brazil Oncology Information System Market Share (%), By Product and Service, 2017-2031F
  • Figure 71.Brazil Oncology Information System Market Share (%), By Application, 2017-2031F
  • Figure 72.Brazil Oncology Information System Market Share (%), By End-user, 2017-2031F
  • Figure 73.Argentina Oncology Information System Market, By Value, In USD Billion, 2017-2031F
  • Figure 74.Argentina Oncology Information System Market Share (%), By Product and Service, 2017-2031F
  • Figure 75.Argentina Oncology Information System Market Share (%), By Application, 2017-2031F
  • Figure 76.Argentina Oncology Information System Market Share (%), By End-user, 2017-2031F
  • Figure 77.Asia-Pacific Oncology Information System Market, By Value, In USD Billion, 2017-2031F
  • Figure 78.Asia-Pacific Oncology Information System Market Share (%), By Product and Service, 2017-2031F
  • Figure 79.Asia-Pacific Oncology Information System Market Share (%), By Application, 2017-2031F
  • Figure 80.Asia-Pacific Oncology Information System Market Share (%), By End-user, 2017-2031F
  • Figure 81.Asia-Pacific Oncology Information System Market Share (%), By Country, 2017-2031F
  • Figure 82.India Oncology Information System Market, By Value, In USD Billion, 2017-2031F
  • Figure 83.India Oncology Information System Market Share (%), By Product and Service, 2017-2031F
  • Figure 84.India Oncology Information System Market Share (%), By Application, 2017-2031F
  • Figure 85.India Oncology Information System Market Share (%), By End-user, 2017-2031F
  • Figure 86.China Oncology Information System Market, By Value, In USD Billion, 2017-2031F
  • Figure 87.China Oncology Information System Market Share (%), By Product and Service, 2017-2031F
  • Figure 88.China Oncology Information System Market Share (%), By Application, 2017-2031F
  • Figure 89.China Oncology Information System Market Share (%), By End-user, 2017-2031F
  • Figure 90.Japan Oncology Information System Market, By Value, In USD Billion, 2017-2031F
  • Figure 91.Japan Oncology Information System Market Share (%), By Product and Service, 2017-2031F
  • Figure 92.Japan Oncology Information System Market Share (%), By Application, 2017-2031F
  • Figure 93.Japan Oncology Information System Market Share (%), By End-user, 2017-2031F
  • Figure 94.Australia Oncology Information System Market, By Value, In USD Billion, 2017-2031F
  • Figure 95.Australia Oncology Information System Market Share (%), By Product and Service, 2017-2031F
  • Figure 96.Australia Oncology Information System Market Share (%), By Application, 2017-2031F
  • Figure 97.Australia Oncology Information System Market Share (%), By End-user, 2017-2031F
  • Figure 98.Vietnam Oncology Information System Market, By Value, In USD Billion, 2017-2031F
  • Figure 99.Vietnam Oncology Information System Market Share (%), By Product and Service, 2017-2031F
  • Figure 100.Vietnam Oncology Information System Market Share (%), By Application, 2017-2031F
  • Figure 101.Vietnam Oncology Information System Market Share (%), By End-user, 2017-2031F
  • Figure 102.South Korea Oncology Information System Market, By Value, In USD Billion, 2017-2031F
  • Figure 103.South Korea Oncology Information System Market Share (%), By Product and Service, 2017-2031F
  • Figure 104.South Korea Oncology Information System Market Share (%), By Application, 2017-2031F
  • Figure 105.South Korea Oncology Information System Market Share (%), By End-user, 2017-2031F
  • Figure 106.Indonesia Oncology Information System Market, By Value, In USD Billion, 2017-2031F
  • Figure 107.Indonesia Oncology Information System Market Share (%), By Product and Service, 2017-2031F
  • Figure 108.Indonesia Oncology Information System Market Share (%), By Application, 2017-2031F
  • Figure 109.Indonesia Oncology Information System Market Share (%), By End-user, 2017-2031F
  • Figure 110.Philippines Oncology Information System Market, By Value, In USD Billion, 2017-2031F
  • Figure 111.Philippines Oncology Information System Market Share (%), By Product and Service, 2017-2031F
  • Figure 112.Philippines Oncology Information System Market Share (%), By Application, 2017-2031F
  • Figure 113.Philippines Oncology Information System Market Share (%), By End-user, 2017-2031F
  • Figure 114.Middle East & Africa Oncology Information System Market, By Value, In USD Billion, 2017-2031F
  • Figure 115.Middle East & Africa Oncology Information System Market Share (%), By Product and Service, 2017-2031F
  • Figure 116.Middle East & Africa Oncology Information System Market Share (%), By Application, 2017-2031F
  • Figure 117.Middle East & Africa Oncology Information System Market Share (%), By End-user, 2017-2031F
  • Figure 118.Middle East & Africa Oncology Information System Market Share (%), By Country, 2017-2031F
  • Figure 119.Saudi Arabia Oncology Information System Market, By Value, In USD Billion, 2017-2031F
  • Figure 120.Saudi Arabia Oncology Information System Market Share (%), By Product and Service, 2017-2031F
  • Figure 121.Saudi Arabia Oncology Information System Market Share (%), By Application, 2017-2031F
  • Figure 122.Saudi Arabia Oncology Information System Market Share (%), By End-user, 2017-2031F
  • Figure 123.UAE Oncology Information System Market, By Value, In USD Billion, 2017-2031F
  • Figure 124.UAE Oncology Information System Market Share (%), By Product and Service, 2017-2031F
  • Figure 125.UAE Oncology Information System Market Share (%), By Application, 2017-2031F
  • Figure 126.UAE Oncology Information System Market Share (%), By End-user, 2017-2031F
  • Figure 127.South Africa Oncology Information System Market, By Value, In USD Billion, 2017-2031F
  • Figure 128.South Africa Oncology Information System Market Share (%), By Product and Service, 2017-2031F
  • Figure 129.South Africa Oncology Information System Market Share (%), By Application, 2017-2031F
  • Figure 130.South Africa Oncology Information System Market Share (%), By End-user, 2017-2031F
  • Figure 131.By Product and Service Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 132.By Application Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 133.By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 134.By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023
目次
Product Code: MX11236

Global oncology information system market is projected to witness a CAGR of 7.35% during the forecast period 2024-2031, growing from USD 3.23 billion in 2023 to USD 5.7 billion in 2031. The growth of the oncology information system (OIS) market is primarily fueled by the increasing prevalence of cancer cases worldwide. There's a rising demand for OIS to streamline patient information and data management, leading to a surge in various types of OIS software. Additionally, increasing investments in cancer research by companies are anticipated to propel market expansion. Governments are increasing their funding for oncology research and development, aligning with the World Health Organization's goal of eliminating cervical cancer as a public health concern by 2030. Such initiatives not only raise awareness but also drive market growth.

In August 2022, the Koita Centre for Digital Oncology (KCDO) was established by the National Cancer Grid (NCG) to promote digital technology and tools for enhancing cancer care across India. The Koita Foundation provided funding for the center's establishment, with commitments for continued support over the next five years. An MoU was signed between the Tata Memorial Centre and Koita Foundation at the Tata Memorial Hospital in Mumbai. These initiatives were expected to contribute to market growth and enhance cancer care in India. The KCDO aims to serve as a platform for collaboration and knowledge exchange among oncology healthcare professionals, researchers, and innovators. Moreover, the center plans to develop and implement digital solutions to enhance cancer screening, diagnosis, and treatment outcomes.

Rising Occurrence of Cancer Cases

The integration of technology and software systems plays a vital role in cancer treatment, given that cancer remains a significant global cause of mortality. The increasing prevalence of cancer, particularly among the elderly due to lifestyle changes, is a key driver for the demand for oncology information systems. Projections for 2022 anticipated 20 million new cancer cases and 9.7 million deaths from the disease, with approximately 53.5 million survivors within five years of diagnosis. Statistics show that one in five individuals will face a cancer diagnosis during their lifetime, with one in nine men and one in twelve women succumbing to the disease. Electronic health record (EHR) systems are being adopted to support evidence-based decision-making among healthcare professionals and streamline patient care coordination. Oncology information systems manage EHRs, improving patient-centric services, understanding disease etiology, enabling early disease detection, and facilitating access to more effective treatment modalities. The demand for precise and efficient radiation detection systems is critical for ensuring patients receive accurate radiation dosages during treatment. Advancements in cancer care are moving towards precision medicine and tailored treatment plans, emphasizing the importance of leveraging information systems to utilize diagnostic results from advanced technologies effectively. These systems store, process, and share documentation, enabling thorough analysis of diagnoses and the formulation of appropriate treatment strategies. As per an article published in January 2022, by the American Cancer Society Journal, the number of cancer cases reported has increased to approximately 1.9 million in the United States.

Rapid Growth in Healthcare IT

The healthcare IT market intersects with various sectors, including medical technology, healthcare, medical devices, and digital health, reshaping traditional healthcare delivery and research systems through modern technological advancements. An integrated healthcare IT ecosystem addresses gaps in oncology care continuity while streamlining processes and reducing inefficiencies. It minimizes healthcare redundancies, enabling hospital systems to deliver patient-centric care seamlessly across healthcare providers. Consequently, adopting different healthcare IT solutions, such as EMR, RIS, PACS, VNA, and treatment planning solutions, has led healthcare organizations to decrease operational expenses while enhancing the quality of care, driving market demand among major end-user segments.

The market is propelled by the increasing adoption of cloud-based solutions, which offer numerous advantages over traditional on-premises alternatives, including enhanced accessibility, scalability, and cost-effectiveness. Cloud-based solutions facilitate seamless integration with EHR systems and other healthcare IT platforms, facilitating the sharing and collaboration of patient data across various healthcare settings. AI and ML algorithms streamline the analysis and interpretation of intricate medical imaging data, enhancing cancer diagnosis and treatment planning accuracy and efficiency.

In February 2023, New Jersey Cancer Care announced the commencement of remote patient monitoring services to drive innovation in oncology. The cancer care center integrates medical devices with patient apps through this initiative, fostering a more connected and proactive approach to patient care.

Dominance of Radiation Oncology

Through the projected period, radiation oncology is expected to experience significant growth at an impressive CAGR. Radiation therapy constitutes a vital aspect of cancer treatment, given the global prominence of cancer as a leading cause of mortality. With the increasing adoption of radiosurgery, the demand for radiation oncology has surged, leading radiological departments to generate extensive data on cancer cases. Effective radiation therapy necessitates treatment planning and simulation to precisely administer radiation doses to target tumors while minimizing harm to surrounding healthy tissues. Oncology information systems offer specialized tools and modules tailored for radiation treatment planning, encompassing dose calculations, treatment simulations, contouring, and image fusion. These systems empower radiation oncologists to devise optimal treatment strategies and simulate the delivery process, ensuring precision and safety. Furthermore, the growing global demand for radiation therapies in cancer treatment catalyzes the segment's expansion. The imperative for precise and efficient radiation detection systems arises to ensure patients receive the correct radiation dosage during treatment. Diagnostic imaging techniques employing ionizing radiation, such as CT scans, PET scans, and X-rays, play a crucial role in cancer diagnosis. Increased government investment in healthcare, as evidenced by data from the National Institutes of Health indicating a rise in US healthcare expenditure for biomedical imaging from USD 2.7 billion in 2022 to USD 3.1 billion in 2023, is also driving the demand for oncology information systems. In February 2024, Kormek Group was awarded £1.3 million (USD 1.6 million) to participate in the Intelligent Radiation Sensor Readout System (i-RASE) project for developing a new class of radiation sensors powered by artificial intelligence (AI).

North America Is Dominating the Global Oncology Information System Market

North America is poised to dominate the oncology information system market throughout the projected timeframe. This can be attributed to factors like the increasing incidence of cancer and the presence of advanced healthcare infrastructure. According to the cancer facts and figures report for 2023 from the American Cancer Society, approximately 1.9 million new cancer cases are expected to be diagnosed in 2023. Notably, prostate cancer is projected to lead with an estimated 288,300 cases, followed by lung cancer with 238,340 cases, and female breast cancer with 300,590 cases. Similarly, data released by the Government of Canada in May 2022 revealed that around 233,900 Canadians received cancer diagnoses in 2022, with prostate cancer anticipated to remain the most diagnosed cancer type. Additionally, increasing awareness campaigns related to cancer are anticipated to drive market growth in the region. The cancer awareness month in September in the United States highlights the government's commitment to support patients and their families, improving access to care, and promoting the importance of early detection. These efforts are likely to raise awareness about cancer and contribute to market expansion in North America over the forecast period.

Future Market Scenario (2024 - 2031F)

The rise in cancer patients presents the biggest opportunity for the growing oncology information system market. Advanced and effective approaches have been devised to ensure faster recovery and better results for keeping health in check for cancer patients. R&D and heavy investments made by healthcare giants are promoting developments in the oncology information system market, and this is a huge advantage for this market to flourish in the coming years. New companies in this area are introducing themselves with cutting-edge technologies. In May 2022, Berry Oncology, a firm specializing in genetic testing and early tumor screening, introduced a HIFI system comprising HIFI-det liquid biopsy technology and the corresponding HIFI-cal algorithm series. Successful attempts made towards the betterment of technology also pushes people to further engage with a higher quality of self-care and this paves a way for the market to rise.

Key Players Landscape and Outlook

Several companies, such as Siemens Healthineers, F. Hoffmann-La Roche AG, McKesson Corporation, Koninklijke Philips N.V., GE HealthCare Technologies, Inc., Elekta AB, IBM Corporation, Oracle Cerner, Epic Systems Corporation, and RaySearch Laboratories AB, are focusing on market expansion and product launch and development. Oncology information system market participants are poised to encounter promising growth prospects in the global market, driven by the increasing demand for healthcare IT solutions. The primary focus of these leading players is directed towards the rapidly expanding market segment, aiming to thrive and excel in an intensely competitive market environment. Additionally, these market players emphasize collaboration and license agreements as strategic initiatives anticipated to propel market growth.

In May 2022, GE Healthcare partnered with RaySearch Laboratories AB, a provider of radiation oncology software, to develop an innovative radiation therapy simulation and treatment planning workflow solution. This collaboration aims to streamline the radiation targeting process to reduce tumor size.

In September 2022, the International Agency for Research on Cancer announced initiating a new research initiative financed by the European Union (EU). The project's primary objective is to enhance the region's cancer screening data collection systems.

Table of Contents

1.Research Methodology

2.Project Scope & Definitions

3.Executive Summary

4.Global Oncology Information System Market Outlook, 2017-2031F

  • 4.1.Market Size & Forecast
    • 4.1.1.By Value
  • 4.2.By Product and Service
    • 4.2.1.Patient Information Systems
    • 4.2.2.Treatment Planning Systems
    • 4.2.3.Treatment Management & Medical Image Analysis Systems
    • 4.2.4.Consulting & Optimization Services
    • 4.2.5.Implementation Services
    • 4.2.6.Post-sale & Maintenance Services
  • 4.3.By Application
    • 4.3.1.Medical Oncology
    • 4.3.2.Radiation Oncology
    • 4.3.3.Surgical Oncology
  • 4.4.By End-user
    • 4.4.1.Hospitals
    • 4.4.2.Cancer Care Centres
    • 4.4.3.Government Institutes
    • 4.4.4.Research Facilities
    • 4.4.5.Others
  • 4.5.By Region
    • 4.5.1.North America
    • 4.5.2.Europe
    • 4.5.3.Asia-Pacific
    • 4.5.4.South End-user America
    • 4.5.5.Middle East and Africa
  • 4.6.By Company Market Share (%), 2023

5.Global Oncology Information System Market Outlook, By Region, 2017-2031F

  • 5.1.North America*
    • 5.1.1.Market Size & Forecast
      • 5.1.1.1.By Value
    • 5.1.2.By Product and Service
      • 5.1.2.1.Patient Information Systems
      • 5.1.2.2.Treatment Planning Systems
      • 5.1.2.3.Treatment Management & Medical Image Analysis Systems
      • 5.1.2.4.Consulting & Optimization Services
      • 5.1.2.5.Implementation Services
      • 5.1.2.6.Post-sale & Maintenance Services
    • 5.1.3.By Application
      • 5.1.3.1.Medical Oncology
      • 5.1.3.2.Radiation Oncology
      • 5.1.3.3.Surgical Oncology
    • 5.1.4.By End-user
      • 5.1.4.1.Hospitals
      • 5.1.4.2.Cancer Care Centres
      • 5.1.4.3.Government Institutes
      • 5.1.4.4.Research Facilities
      • 5.1.4.5.Others
    • 5.1.5.United States*
      • 5.1.5.1.Market Size & Forecast
      • 5.1.5.1.1.By Value
      • 5.1.5.2.By Product and Service
      • 5.1.5.2.1.Patient Information Systems
      • 5.1.5.2.2.Treatment Planning Systems
      • 5.1.5.2.3.Treatment Management & Medical Image Analysis Systems
      • 5.1.5.2.4.Consulting & Optimization Services
      • 5.1.5.2.5.Implementation Services
      • 5.1.5.2.6.Post-sale & Maintenance Services
      • 5.1.5.3.By Application
      • 5.1.5.3.1.Medical Oncology
      • 5.1.5.3.2.Radiation Oncology
      • 5.1.5.3.3.Surgical Oncology
      • 5.1.5.4.By End-user
      • 5.1.5.4.1.Hospitals
      • 5.1.5.4.2.Cancer Care Centres
      • 5.1.5.4.3.Government Institutes
      • 5.1.5.4.4.Research Facilities
      • 5.1.5.4.5.Others
    • 5.1.6.Canada
    • 5.1.7.Mexico

All segments will be provided for all regions and countries covered

  • 5.2.Europe
    • 5.2.1.Germany
    • 5.2.2.France
    • 5.2.3.Italy
    • 5.2.4.United Kingdom
    • 5.2.5.Russia
    • 5.2.6.Netherlands
    • 5.2.7.Spain
    • 5.2.8.Turkey
    • 5.2.9.Poland
  • 5.3.Asia-Pacific
    • 5.3.1.India
    • 5.3.2.China
    • 5.3.3.Japan
    • 5.3.4.Australia
    • 5.3.5.Vietnam
    • 5.3.6.South Korea
    • 5.3.7.Indonesia
    • 5.3.8.Philippines
  • 5.4.South America
    • 5.4.1.Brazil
    • 5.4.2.Argentina
  • 5.5.Middle East & Africa
    • 5.5.1.Saudi Arabia
    • 5.5.2.UAE
    • 5.5.3.South Africa

6.Market Mapping, 2023

  • 6.1.By Product and Service
  • 6.2.By Application
  • 6.3.By End-user
  • 6.4.By Region

7.Macro Environment and Industry Structure

  • 7.1.Demand Supply Analysis
  • 7.2.Import Export Analysis
  • 7.3.Value Chain Analysis
  • 7.4.PESTEL Analysis
    • 7.4.1.Political Factors
    • 7.4.2.Economic System
    • 7.4.3.Social Implications
    • 7.4.4.Technological Advancements
    • 7.4.5.Environmental Impacts
    • 7.4.6.Legal Compliances and Regulatory Policies (Statutory Bodies Included)
  • 7.5.Porter's Five Forces Analysis
    • 7.5.1.Supplier Power
    • 7.5.2.Buyer Power
    • 7.5.3.Substitution Threat
    • 7.5.4.Threat from New Entrant
    • 7.5.5.Competitive Rivalry

8.Market Dynamics

  • 8.1.Growth Drivers
  • 8.2.Growth Inhibitors (Challenges and Restraints)

9.Regulatory Framework and Innovation

  • 9.1.Patent Landscape
  • 9.2.Innovations/Emerging Technologies

10.Key Players Landscape

  • 10.1.Competition Matrix of Top Five Market Leaders
  • 10.2.Market Revenue Analysis of Top Five Market Leaders (in %, 2023)
  • 10.3.Mergers and Acquisitions/Joint Ventures (If Applicable)
  • 10.4.SWOT Analysis (For Five Market Players)

11.Case Studies

12.Key Players Outlook

  • 12.1.Siemens Healthineers
    • 12.1.1.Company Details
    • 12.1.2.Key Management Personnel
    • 12.1.3.Products & Services
    • 12.1.4.Financials (As reported)
    • 12.1.5.Key Market Focus & Geographical Presence
    • 12.1.6.Recent Developments
  • 12.2.F. Hoffmann-La Roche AG
  • 12.3.McKesson Corporation
  • 12.4.Koninklijke Philips N.V.
  • 12.5.GE HealthCare Technologies, Inc.
  • 12.6.Elekta Medical Systems India Pvt. Ltd.
  • 12.7.IBM Watson Health
  • 12.8.Oracle Cerner
  • 12.9.Epic Systems Corporation
  • 12.10.RaySearch Laboratories AB

13.Strategic Recommendations

14.About Us & Disclaimer